Biomerica Dividends

BMRA Stock  USD 0.75  0.01  1.35%   
The current year's Dividend Paid And Capex Coverage Ratio is expected to grow to 66.32. Biomerica's past performance could be the main factor of why investors trade Biomerica stock today. Investors should clearly understand every aspect of the Biomerica dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Biomerica's dividend schedule and payout information. Biomerica dividends can also provide a clue to the current valuation of Biomerica.
Last ReportedProjected for Next Year
Dividends Paid 0.00  0.00 
Dividend Yield 0.00  0.00 
Dividend Payout Ratio 0.00  0.00 
Dividend Paid And Capex Coverage Ratio 63.16  66.32 
One of the primary advantages of investing in dividend-paying companies such as Biomerica is that dividends usually grow steadily over time. As a result, well-established companies that pay dividends typically increase their dividend payouts yearly, which many long-term traders find attractive.
  
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Biomerica must own a stock before its ex-dividend date to receive its next dividend.

Is Biomerica's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomerica. If investors know Biomerica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomerica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.37)
Revenue Per Share
0.323
Quarterly Revenue Growth
(0.09)
Return On Assets
(0.43)
Return On Equity
(0.92)
The market value of Biomerica is measured differently than its book value, which is the value of Biomerica that is recorded on the company's balance sheet. Investors also form their own opinion of Biomerica's value that differs from its market value or its book value, called intrinsic value, which is Biomerica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomerica's market value can be influenced by many factors that don't directly affect Biomerica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomerica's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomerica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomerica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Compare Dividends Across Peers

Specify up to 10 symbols: